US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 52.050
  • -0.510-0.97%
Close Apr 30 16:00 ET
  • 52.280
  • +0.230+0.44%
Post 19:51 ET
11.69BMarket Cap15.77P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-48.81%496.49M
-47.92%147.73M
-50.12%147.84M
76.01%306.53M
-148.95%-105.6M
29.41%969.94M
145.91%283.66M
16.18%296.38M
0.70%174.16M
4.68%215.74M
Net income from continuing operations
75.42%597.6M
606.51%201.08M
51.87%171.27M
26.09%203.55M
-42.87%21.7M
-64.09%340.66M
-94.95%28.46M
-37.95%112.78M
8.01%161.43M
-29.03%37.99M
Depreciation and amortization
21.82%82.66M
19.45%21.76M
28.15%21.39M
22.96%20.3M
16.87%19.21M
17.31%67.86M
22.61%18.22M
13.62%16.69M
14.18%16.51M
18.79%16.44M
Deferred tax
-378.32%-158.9M
-496.06%-65.98M
-490.29%-31.06M
-230.73%-39.7M
-1,152.37%-22.16M
112.26%57.09M
103.58%16.66M
44,305.56%7.96M
13,303.91%30.37M
2,908.57%2.11M
Other non cash items
75.44%51.78M
43.45%38.18M
117.70%2.7M
-24.09%7.36M
-58.16%3.55M
82.66%29.52M
1,322.04%26.62M
-407.47%-15.26M
200.53%9.69M
-16.51%8.47M
Change In working capital
-225.07%-248.65M
-158.33%-73.25M
-171.10%-91.12M
188.79%102.32M
-409.42%-186.6M
1,464.61%198.81M
416.69%125.58M
880.39%128.16M
-865.91%-115.23M
12.85%60.31M
-Change in receivables
-245.28%-98.68M
-223.31%-86.29M
-129.75%-19.27M
88.22%-14.21M
-60.91%21.09M
78.72%-28.58M
73.20%-26.69M
182.50%64.78M
-195.55%-120.62M
-36.25%53.96M
-Change in inventory
-152.06%-170.15M
-384.46%-92.96M
-113.53%-23.76M
13.62%-20.12M
-139.66%-33.32M
-221.98%-67.5M
-303.96%-19.19M
-15,552.78%-11.13M
-96.00%-23.29M
-215.55%-13.9M
-Change in prepaid assets
-38.23%-42.49M
111.17%19.59M
-268.01%-53.86M
241.42%16.14M
-74.32%-24.35M
52.03%-30.74M
123.61%9.28M
32.87%-14.64M
-246.34%-11.41M
-29.64%-13.97M
-Change in payables and accrued expense
-80.75%62.67M
-46.72%86.41M
-93.53%5.76M
200.61%120.51M
-538.33%-150.01M
59.01%325.63M
55.94%162.18M
6.33%89.14M
21.59%40.09M
313.67%34.22M
Cash from discontinued investing activities
Operating cash flow
-48.81%496.49M
-47.92%147.73M
-50.12%147.84M
76.01%306.53M
-148.95%-105.6M
29.41%969.94M
145.91%283.66M
16.18%296.38M
0.70%174.16M
4.68%215.74M
Investing cash flow
Cash flow from continuing investing activities
-164.42%-207.68M
-638.81%-154.5M
39.48%-17.19M
40.47%-7.43M
-70.52%-28.56M
62.18%-78.54M
68.34%-20.91M
13.29%-28.4M
74.61%-12.48M
71.97%-16.75M
Capital expenditure reported
58.26%-32.49M
89.34%-2.27M
60.53%-10.98M
37.52%-7.34M
29.99%-11.91M
57.00%-77.83M
38.27%-21.27M
13.50%-27.81M
82.29%-11.74M
64.63%-17.01M
Net intangibles purchase and sale
---15M
--0
--0
--0
---15M
--0
--0
--0
--0
--0
Net investment purchase and sale
-22,493.94%-160.19M
-42,269.81%-152.23M
-951.27%-6.21M
87.52%-92K
-740.70%-1.65M
97.34%-709K
101.14%361K
1.66%-591K
-104.29%-737K
102.21%258K
Cash from discontinued investing activities
Investing cash flow
-164.42%-207.68M
-638.81%-154.5M
39.48%-17.19M
40.47%-7.43M
-70.52%-28.56M
62.18%-78.54M
68.34%-20.91M
13.29%-28.4M
74.61%-12.48M
71.97%-16.75M
Financing cash flow
Cash flow from continuing financing activities
-2,423.05%-20.03M
113.95%346K
-160.33%-37.26M
-19.07%12.87M
4,076.04%4.01M
-112.86%-794K
-127.54%-2.48M
26.01%-14.31M
332.21%15.9M
-99.25%96K
Net issuance payments of debt
-17.40%-3.36M
-10.71%-837K
-19.92%-885K
-19.43%-836K
-20.06%-802K
-18.41%-2.86M
-20.19%-756K
-20.00%-738K
-16.67%-700K
-16.58%-668K
Proceeds from stock option exercised by employees
-41.36%35.84M
-58.53%7.52M
-100.91%-48K
-32.47%14.38M
-14.70%13.99M
4.25%61.12M
77.81%18.13M
11.21%5.3M
0.00%21.29M
-26.72%16.4M
Net other financing activities
11.07%-52.51M
68.09%-6.33M
-92.49%-36.32M
85.62%-675K
41.30%-9.18M
-18.02%-59.05M
-3,444.64%-19.85M
19.67%-18.87M
72.42%-4.69M
-74.33%-15.63M
Cash from discontinued financing activities
Financing cash flow
-2,423.05%-20.03M
113.95%346K
-160.33%-37.26M
-19.07%12.87M
4,076.04%4.01M
-112.86%-794K
-127.54%-2.48M
26.01%-14.31M
332.21%15.9M
-99.25%96K
Net cash flow
Beginning cash position
43.41%2.95B
19.94%3.23B
28.55%3.13B
24.99%2.82B
43.41%2.95B
35.94%2.06B
34.56%2.69B
35.45%2.44B
35.11%2.26B
35.94%2.06B
Current changes in cash
-69.82%268.78M
-102.47%-6.43M
-63.18%93.39M
75.68%311.97M
-165.37%-130.15M
62.53%890.61M
346.36%260.27M
24.96%253.67M
39.30%177.58M
25.07%199.09M
Effect of exchange rate changes
-298.99%-6.68M
-1,264.43%-7.3M
77.45%2.72M
-291.40%-1.89M
-194.76%-199K
193.98%3.36M
323.65%627K
198.14%1.53M
474.42%988K
109.01%210K
End cash Position
8.88%3.22B
8.88%3.22B
19.94%3.23B
28.55%3.13B
24.99%2.82B
43.41%2.95B
43.41%2.95B
34.56%2.69B
35.45%2.44B
35.11%2.26B
Free cash flow
-49.67%449M
-44.56%145.46M
-49.04%136.86M
84.21%299.19M
-166.68%-132.51M
56.93%892.11M
224.39%262.39M
20.46%268.57M
52.31%162.41M
25.77%198.74M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -48.81%496.49M-47.92%147.73M-50.12%147.84M76.01%306.53M-148.95%-105.6M29.41%969.94M145.91%283.66M16.18%296.38M0.70%174.16M4.68%215.74M
Net income from continuing operations 75.42%597.6M606.51%201.08M51.87%171.27M26.09%203.55M-42.87%21.7M-64.09%340.66M-94.95%28.46M-37.95%112.78M8.01%161.43M-29.03%37.99M
Depreciation and amortization 21.82%82.66M19.45%21.76M28.15%21.39M22.96%20.3M16.87%19.21M17.31%67.86M22.61%18.22M13.62%16.69M14.18%16.51M18.79%16.44M
Deferred tax -378.32%-158.9M-496.06%-65.98M-490.29%-31.06M-230.73%-39.7M-1,152.37%-22.16M112.26%57.09M103.58%16.66M44,305.56%7.96M13,303.91%30.37M2,908.57%2.11M
Other non cash items 75.44%51.78M43.45%38.18M117.70%2.7M-24.09%7.36M-58.16%3.55M82.66%29.52M1,322.04%26.62M-407.47%-15.26M200.53%9.69M-16.51%8.47M
Change In working capital -225.07%-248.65M-158.33%-73.25M-171.10%-91.12M188.79%102.32M-409.42%-186.6M1,464.61%198.81M416.69%125.58M880.39%128.16M-865.91%-115.23M12.85%60.31M
-Change in receivables -245.28%-98.68M-223.31%-86.29M-129.75%-19.27M88.22%-14.21M-60.91%21.09M78.72%-28.58M73.20%-26.69M182.50%64.78M-195.55%-120.62M-36.25%53.96M
-Change in inventory -152.06%-170.15M-384.46%-92.96M-113.53%-23.76M13.62%-20.12M-139.66%-33.32M-221.98%-67.5M-303.96%-19.19M-15,552.78%-11.13M-96.00%-23.29M-215.55%-13.9M
-Change in prepaid assets -38.23%-42.49M111.17%19.59M-268.01%-53.86M241.42%16.14M-74.32%-24.35M52.03%-30.74M123.61%9.28M32.87%-14.64M-246.34%-11.41M-29.64%-13.97M
-Change in payables and accrued expense -80.75%62.67M-46.72%86.41M-93.53%5.76M200.61%120.51M-538.33%-150.01M59.01%325.63M55.94%162.18M6.33%89.14M21.59%40.09M313.67%34.22M
Cash from discontinued investing activities
Operating cash flow -48.81%496.49M-47.92%147.73M-50.12%147.84M76.01%306.53M-148.95%-105.6M29.41%969.94M145.91%283.66M16.18%296.38M0.70%174.16M4.68%215.74M
Investing cash flow
Cash flow from continuing investing activities -164.42%-207.68M-638.81%-154.5M39.48%-17.19M40.47%-7.43M-70.52%-28.56M62.18%-78.54M68.34%-20.91M13.29%-28.4M74.61%-12.48M71.97%-16.75M
Capital expenditure reported 58.26%-32.49M89.34%-2.27M60.53%-10.98M37.52%-7.34M29.99%-11.91M57.00%-77.83M38.27%-21.27M13.50%-27.81M82.29%-11.74M64.63%-17.01M
Net intangibles purchase and sale ---15M--0--0--0---15M--0--0--0--0--0
Net investment purchase and sale -22,493.94%-160.19M-42,269.81%-152.23M-951.27%-6.21M87.52%-92K-740.70%-1.65M97.34%-709K101.14%361K1.66%-591K-104.29%-737K102.21%258K
Cash from discontinued investing activities
Investing cash flow -164.42%-207.68M-638.81%-154.5M39.48%-17.19M40.47%-7.43M-70.52%-28.56M62.18%-78.54M68.34%-20.91M13.29%-28.4M74.61%-12.48M71.97%-16.75M
Financing cash flow
Cash flow from continuing financing activities -2,423.05%-20.03M113.95%346K-160.33%-37.26M-19.07%12.87M4,076.04%4.01M-112.86%-794K-127.54%-2.48M26.01%-14.31M332.21%15.9M-99.25%96K
Net issuance payments of debt -17.40%-3.36M-10.71%-837K-19.92%-885K-19.43%-836K-20.06%-802K-18.41%-2.86M-20.19%-756K-20.00%-738K-16.67%-700K-16.58%-668K
Proceeds from stock option exercised by employees -41.36%35.84M-58.53%7.52M-100.91%-48K-32.47%14.38M-14.70%13.99M4.25%61.12M77.81%18.13M11.21%5.3M0.00%21.29M-26.72%16.4M
Net other financing activities 11.07%-52.51M68.09%-6.33M-92.49%-36.32M85.62%-675K41.30%-9.18M-18.02%-59.05M-3,444.64%-19.85M19.67%-18.87M72.42%-4.69M-74.33%-15.63M
Cash from discontinued financing activities
Financing cash flow -2,423.05%-20.03M113.95%346K-160.33%-37.26M-19.07%12.87M4,076.04%4.01M-112.86%-794K-127.54%-2.48M26.01%-14.31M332.21%15.9M-99.25%96K
Net cash flow
Beginning cash position 43.41%2.95B19.94%3.23B28.55%3.13B24.99%2.82B43.41%2.95B35.94%2.06B34.56%2.69B35.45%2.44B35.11%2.26B35.94%2.06B
Current changes in cash -69.82%268.78M-102.47%-6.43M-63.18%93.39M75.68%311.97M-165.37%-130.15M62.53%890.61M346.36%260.27M24.96%253.67M39.30%177.58M25.07%199.09M
Effect of exchange rate changes -298.99%-6.68M-1,264.43%-7.3M77.45%2.72M-291.40%-1.89M-194.76%-199K193.98%3.36M323.65%627K198.14%1.53M474.42%988K109.01%210K
End cash Position 8.88%3.22B8.88%3.22B19.94%3.23B28.55%3.13B24.99%2.82B43.41%2.95B43.41%2.95B34.56%2.69B35.45%2.44B35.11%2.26B
Free cash flow -49.67%449M-44.56%145.46M-49.04%136.86M84.21%299.19M-166.68%-132.51M56.93%892.11M224.39%262.39M20.46%268.57M52.31%162.41M25.77%198.74M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday-0.79%